首页> 外国专利> AGENTS TARGETING SNAT7 FOR TREATING CELLULAR METABOLISM REPROGRAMMING-ASSOCIATED DISEASES

AGENTS TARGETING SNAT7 FOR TREATING CELLULAR METABOLISM REPROGRAMMING-ASSOCIATED DISEASES

机译：代理商针对SNAT7来治疗细胞代谢重编程相关疾病

页面导航

摘要
著录项
相似文献

摘要

The present application relates to therapeutic agent reducing the expression or the activity of the SNAT7 transporter, encoded by the SLC38A7 gene or one of its variants for use in the treatment of a cellular metabolism reprogramming-associated disease, preferentially a cancer depending on glutamine, more preferentially a cancer depending on glutamine activated by one or more oncogenes selected from Ras, Myc and Src, even more preferentially a cancer depending on glutamine activated by Ras. The present invention also relates to a pharmaceutical composition comprising at least one therapeutic agent for use according to the invention, or at least one expression vector according expressing said therapeutic agent for use to the invention.

机译：本申请涉及降低由 SLC38A7 基因或其变体之一编码的SNAT7转运蛋白的表达或活性的治疗剂，优选用于治疗与细胞代谢重编程相关的疾病取决于谷氨酰胺的癌症，更优选取决于由一种或多种选自Ras，Myc和Src的癌基因激活的谷氨酰胺的癌症，甚至更优选取决于由Ras激活的谷氨酰胺的癌症。本发明还涉及药物组合物，其包含至少一种根据本发明使用的治疗剂，或至少一种根据表达所述用于本发明的治疗剂的表达载体。 展开▼

著录项

公开/公告号EP3263706A1

专利类型

公开/公告日2018-01-03

原文格式PDF

申请/专利权人 CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE -CNRS-;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM);UNIVERSITE PARIS-SUD;UNIVERSITE PARIS DESCARTES;
展开▼

申请/专利号EP20160305785

发明设计人 SAGNE CORINNE;GASNIER BRUNO;VERDON QUENTIN;
展开▼

申请日2016-06-28

分类号C12N15/113;C07K16/28;

国家 EP

入库时间 2022-08-21 13:14:57

相似文献

专利

外文文献

中文文献

1. 通过抑制针对重编程因子的天然反义转录物来治疗重编程因子相关的疾病 [P] . 中国专利： CN102575251B . 2018.12.04

2. 通过抑制针对重编程因子的天然反义转录物来治疗重编程因子相关的疾病 [P] . 中国专利： CN102575251A . 2012-07-11

3. compound, method of treating or preventing cancer, an infectious disease, or a condition called aberration of cellular energy metabolism in an individual, method of treating or preventing leukemia, non-small cell lung cancer, hepatocellular carcinoma, or glioblastomas in an individual, method of treating a disease or disorder in an individual, pharmaceutical composition and process for obtaining a compound of formula (i) [P] . BR112016028219A2 . 2018-11-27

机译：化合物，个体中治疗或预防癌症，传染病或称为细胞能量代谢异常的病症，个体中治疗或预防白血病，非小细胞肺癌，肝细胞癌或胶质母细胞瘤的方法，方法个体中治疗疾病或病症的方法，药物组合物和获得式（i）化合物的方法

4. TARGETING LIPID METABOLISM AND FREE FATTY ACID (FFA) OXIDATION TO TREAT DISEASES MEDIATED BY RESIDENT MEMORY T CELLS (TRM) [P] . EP3755322A4 . 2021-12-29

机译：靶向脂质代谢和游离脂肪酸（FFA）氧化以治疗由驻留仪T细胞（TRM）介导的疾病

5. TARGETING LIPID METABOLISM AND FREE FATTY ACID (FFA) OXIDATION TO TREAT DISEASES MEDIATED BY RESIDENT MEMORY T CELLS (TRM) [P] . 世界知识产权组织专利： WO2019161294A1 . 2019-08-22

机译：以脂质代谢和游离脂肪酸（FFA）氧化为目标，治疗残留性T细胞（TRM）介导的疾病

1. Targeting the epigenome to treat neurodegenerative diseases or delay their onset: a perspective [J] . Fabio Coppedè 中国神经再生研究（英文版） . 2022,第008期

2. Proteolysis targeting chimera technology: a novel strategy for treating diseases of the central nervous system [J] . Ke Ma, Xiao-Xiao Han, Xiao-Ming Yang, 中国神经再生研究（英文版） . 2021,第010期

3. One patient with metastastic colorectal cancer successfully treated by combination of targeted agents after failure of chemotherpay [J] . Liang-Ping Xia, Pei-Hong Wu, Jian-Chuan Xia, 癌症（英文版） . 2010,第012期

4. AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases Thematic Review Series: New Lipid and Lipoprotein Targets for the Treatment of Cardiometabolic Diseases [J] . Rai Ajit K. Srivastava, Stephen L. Pinkosky, Sergey Filippov, Journal of Lipid Research . 2012,第12期

5. Essential viral and cellular zinc and iron containing metalloproteins as targets for novel antiviral and anticancer agents: implications for prevention and therapy of viral diseases and cancer. [J] . Fernandez-Pol JA, Hamilton PD, Klos DJ Anticancer Research: International Journal of Cancer Research and Treatment . 2001,第2Appa期

6. Infections in patients with lymphoproliferative diseases treated with targeted agents: SEIFEM multicentric retrospective study [J] . Marchesini Gessica, Nadali Gianpaolo, Facchinelli Davide, British Journal of Haematology . 2021,第2期

7. Therapeutic Metabolomics Identifies Fatty Acid Metabolism as a Target for Treating Multiple Sclerosis [C] . Leah Shriver, Gary Patti, Bridgit Crews, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2010

8. Design and Synthesis of Pyrimidine Based Heterocycles as Potential Anti-cancer Agents with Combination Chemotherapeutic Potential or Targeted One Carbon Metabolism Inhibition and Anti-opportunistic Agents [D] . Doshi, Arpit. 2019

9. Transcript Profiling of MRSA Biofilms Treated with a Halogenated Phenazine Eradicating Agent: A Platform for Defining Cellular Targets and Pathways Critical to Biofilm Survival [O] . Yasmeen Abouelhassan, Yanping Zhang, Shouguang Jin, -1

10. Poster session 2Morphogenetic mechanisms290MiR-133 regulates retinoic acid pathway during early cardiac chamber specification291Bmp2 regulates atrial differentiation through miR-130 during early heart looping formationDevelopmental genetics294Association of deletion allele of insertion/deletion polymorphism in alpha 2B adrenoceptor gene and hypertension with or without type 2 diabetes mellitus295Association of G1359A polymorphism of the endocannabinoid type 1 receptor (CNR1) with coronary artery disease (CAD) with type 2 diabetes mellitusCell growth, differentiation and stem cells - Vascular298Gamma-secretase inhibitor prevents proliferation and migration of ductus arteriosus smooth muscle cells: a role of Notch signaling in postnatal closure of ductus arteriosus299Mesenchymal stromal-like cells (MLCs) derived from induced pluripotent stem (iPS) cells: a promising therapeutic option to promote neovascularization300Sonic Hedgehog promotes mesenchymal stem cell differentiation to vascular smooth muscle cells in cardiovacsular disease301Proinflammatory cytokine secretion and epigenetic modification in endothelial cells treated LPS-GinfivalisCell death and apoptosis - Vascular304Mitophagy acts as a safeguard mechanism against human vascular smooth muscle cell apoptosis induced by atherogenic lipidsTranscriptional control and RNA species - Vascular307MicroRNA-34a role in vascular calcification308Local delivery of a miR-146a inhibitor utilizing a clinically applicable approach attenuates neointima formation after vascular injury309Long noncoding RNA landscape of hypoxic endothelial cells310Specific circulating microRNAs levels associate with hypertension, hyperglycemia and dysfunctional HDL in acute coronary syndrome patientsCytokines and cellular inflammation - Vascular313Phosphodiesterase5A up-regulation in vascular endothelium under pro-inflammatory conditions: a newly disclosed anti-inflammatory activity for the omega-3polyunsaturated aatty acid docosahexaenoic acid314Cardiovascular risk modifying with extra-low dose anticytokine drugs in rhematoid arthritis315Conversion of human M-CSF macrophages into foam cells reduces their proinflammatory responses to classical M1-polarizing activation316Lymphocytic myocarditis coincides with increased plaque inflammation and plaque hemorrhage in coronary arteries, facilitating myocardial infarction317Serum osteoprotegerin level predictsdeclined numerous of circulating endothelial- derived and mononuclear-derived progenitor cells in patients with metabolic syndromeGrowth factors and neurohormones - Vascular320Effect of gastrin-releasing peptide (GRP) on vascular inflammationSignal transduction - Heart323A new synthetic peptide regulates hypertrophy in vitro through means of the inhibition of nfkb324Inducible fibroblast-specific knockout of p38 alpha map kinase is cardioprotective in a mouse model of isoproterenol-induced cardiac hypertrophy325Regulation of beta-adrenoceptor-evoked inotropic responses by inhibitory G protein, adenylyl cyclase isoforms 5 and 6 and phosphodiesterases326Binding to RGS3 and stimulation of M2 muscarinic acetylcholine receptors modulates the substrate specificity of p190RhoGAP in cardiac myocytes327Cardiac regulation of post-translational modifications, parylation and deacetylation in LMNA dilated cardiomyopathy mouse model328Beta-adrenergic regulation of the b56delta/pp2a holoenzyme in cardiac myocytes through b56delta phosphorylation at serine 573Nitric oxide and reactive oxygen species - Vascular331Oxidative stress-induced miR-200c disrupts the regulatory loop among SIRT1, FOXO1 and eNOS332Antioxidant therapy prevents oxidative stress-induced endothelial dysfunction and Enhances Wound Healing333Morphological and biochemical characterization of red blood cell in coronary artery diseaseCytoskeleton and mechanotransduction - Heart336Novel myosin activator, JSH compounds, increased myocardial contractility without chronotropic effect in ratsExtracellular matrix and fibrosis - Vascular339Ablation of Toll-like receptor 9 causes cardiac rupture after myocardial infarction by attenuating proliferation and differentiation of cardiac fibroblasts340Altered vascular remodeling in the mouse hind limb ischemia model in Factor VII activating protease (FSAP) deficiencyVasculogenesis, angiogenesis and arteriogenesis343Pro-angiogenic effects of proly-hydroxylase inhibitors and their potential for use in a novel strategy of therapeutic angiogenesis for coronary total occlusion344Nrf2 drives angiogenesis in transcription-independent manner: new function of the master regulator of oxidative stress response345Angiogenic gene therapy, despite efficient vascular growth, is not able to improve muscle function in normoxic or chronically ischemic rabbit hindlimbs -role of capillary arterialization and shunting346Effect of PAR-1 inhibition on collateral vessel growth in the murine hind limb model347Quaking is a key regulator of endothelial cell differentiation, neovascularization and angiogenesis348"Emerging angiogenesis" in the chick chorioallantoic membrane (CAM). An in vivo study349Exosomes from cardiomyocyte progenitor cells and mesenchymal stem cells stimulate angiogenesis in vitro and in vivo via EMMPRINEndothelium352Reciprocal regulation of GRK2 and bradykinin receptor stimulation modulate Ca2+ intracellular level in endothelial cells353The roles of bone morphogenetic proteins 9 and 10 in endothelial inflammation and atherosclerosis354The contribution of GPR55 to the L-alpha-lysophosphatidylinositol-induced vasorelaxation in isolated human pulmonary arteries355The endothelial protective ACE inhibitor Zofenoprilat exerts anti-inflammatory activities through H2S production356A new class of glycomimetic drugs to prevent free fatty acid-induced endothelial dysfunction357Endothelial progenitor cells to apoptotic endothelial cell-derived microparticles ration differentiatesas preserved from reduced ejection fractionheart failure358Proosteogenic genes are activated in endothelial cells of patients with thoracic aortic aneurysm359Endothelin ETB receptors mediate relaxing responses to insulin in pericardial resistance arteries from patients with cardiovascular disease (CVD)Smooth muscle and pericytes362CX3CR1 positive myeloid cells regulate vascular smooth muscle tone by inducing calcium oscillations via activation of IP3 receptors363A novel function of PI3Kg on cAMP regulation, role in arterial wall hyperplasia through modulation of smooth muscle cells proliferation364NRP1 and NRP2 play important roles in the development of neointimal hyperplasia in vivo365Azithromycin induces autophagy in aortic smooth muscle cellsCoagulation, thrombosis and platelets368The real time in vivo evaluation of platelet-dependent aldosterone prothrombotic action in mice369Development of a method for in vivo detection of active thrombi in mice370The antiplatelet effects of structural analogs of the taurine chloramine371The influence of heparin anticoagulant drugs on functional state of human platelets372Regulation of platelet aggregation and adenosine diphosphate release by d dimer in acute coronary syndrome (in vitro study)Oxygen sensing, ischaemia and reperfusion375Sirtuin 5 mediates brain injury in a mouse model of cerebral ischemia-reperfusion376Abscisic acid: a new player in cardiomyocyte protection from ischaemia?377Protective effects of ultramicronized palmitoylethanolamide (PEA-um) in myocardial ischaemia and reperfusion injury in vivo378Identification of stem cell-derived cardiomyocytes using cardiac specific markers and additional testing of these cells in simulated ischemia/reperfusion system379Single-dose intravenous metformin treatment could afford significant protection of the injured rat kidney in an experimental model of ischemia-reperfusion380Cardiotoxicity of long acting muscarinic receptor antagonists used for chronic obstructive pulmonary disease381Dependence antioxidant potential on the concentration of amino acids382The impact of ischemia-reperfusion on physiological parameters,apoptosis and ultrastructure of rabbit myocardium with experimental aterosclerosisMitochondria and energetics385MicroRNA-1 dependent regulation of mitochondrial calcium uniporter (MCU) in normal and hypertrophied hearts386Mitochondrial homeostasis and cardioprotection: common targets for desmin and aB-crystallin387Overexpression of mitofusin-2 (Mfn2) and associated mitochondrial dysfunction in the diabetic heart388NO-dependent prevention of permeability transition pore (MPTP) opening by H2S and its regulation of Ca2+ accumulation in rat heart mitochondria389G protein coupled receptor kinase 2 (GRK2) is fundamental in recovering mitochondrial morphology and function after exposure to ionizing radiation (IR)Gender issues392Sex differences in pulmonary vascular control; focus on the nitric oxide pathwayAging395Heart failure with preserved ejection fraction develops when feeding western diet to senescence-accelerated mice396Cardiovascular markers as predictors of cognitive decline in elderly hypertensive patients397Changes in connexin43 in old rats with volume overload chronic heart failureGenetics and epigenetics400Calcium content in the aortic valve is associated with 1G>2G matrix metalloproteinase 1 polymorphism401Neuropeptide receptor gene s (NPSR1) polymorphism and sleep disturbances402Endothelin-1 gene Lys198Asn polymorphism in men with essential hypertension complicated and uncomplicated with chronic heart failure403Association of common polymorphisms of the lipoprotein lipase and pon1 genes with the metabolic syndrome in a sample of community participantsGenomics, proteomics, metabolomics, lipidomics and glycomics405Gene expression quantification using multiplexed color-coded probe pairs to determine RNA content in sporadic cardiac myxoma406Large-scale phosphorylation study of the type 2 diabetic heart subjected to ischemia / reperfusion injury407Transcriptome-based identification of new anti-inflammatory properties of the olive oil hydroxytyrosol in vascular endothelial cell under basal and proinflammatory conditions408Gene polymorphisms combinations and risk of myocardial infarctionComputer modelling, bioinformatics and big data411Comparison of the repolarization reserve in three state-of-the-art models of the human ventricular action potentialMetabolism, diabetes mellitus and obesity414Endothelial monocyte-activating polypeptide-II improves heart function in type -I Diabetes mellitus415Admission glucose level is independent predictor of impaired left ventricular function in patients with acute myocardial infarction: a two dimensional speckle-tracking echocardiography study416Association between biochemical markers of lipid profile and inflammatory reaction and stiffness of the vascular wall in hypertensive patients with abdominal obesity417Multiple common co-morbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress and myocardial stiffening418Investigating the cardiovascular effects of antiretroviral drugs in a lean and high fat/sucrose diet rat model of obesity419Statins in the treatment of non-alcoholic steatohepatitis (NASH). Our experience from a 2-year prospective study in Constanta County, Romania420Epicardial adipose tissue as a predictor of cardiovascular outcome in patients with ACS undergoing PCI?Arterial and pulmonary hypertension423Dependence between heart rhythm disorers and ID polymorphism of ACE gene in hypertensive patients424Molecular mechanisms underlying the beneficial effects of Urocortin 2 in pulmonary arterial hypertension425Inhibition of TGf-b axis and action of renin-angiotensin system in human ascending aorta aneurysms426Early signs of microcirculation and macrocirculation abnormalities in prehypertension427Vascular smooth muscle cell-expressed Tie-2 controls vascular tone428Cardiac and vascular remodelling in the development of chronic thrombo-embolic pulmonary hypertension in a novel swine modelBiomarkers431Arrhythmogenic cardiomyopathy: a new, non invasive biomarker432Can circulating microRNAs distinguish type 1 and type 2 myocardial infarction?433Design of a high-throughput multiplex proteomics assay to identify left ventricular diastolic dysfunction in diabetes434Monocyte-derived and P-selectin-carrying microparticles are differently modified by a low fat diet in patients with cardiovascular risk factors who will and who will not develop a cardiovascular event435Red blood cell distribution width assessment by polychromatic interference microscopy of thin films in chronic heart failure436Invasive and noninvasive evaluation of quality of radiofrequency-induced cardiac denervation in patients with atrial fibrillation437The effect of therapeutic hypothermia on the level of brain derived neurotrophic factor (BDNF) in sera following cardiopulmonary resustitation438Novel biomarkers to predict outcome in patients with heart failure and severe aortic stenosis439Biological factors linking depression and anxiety to cardiovascular disease440Troponins and myoglobin dynamic at coronary arteries graftingInvasive, non-invasive and molecular imaging443Diet composition effects on the genetic typing of the mouse ob mutation: a micro-ultrasound characterization of cardiac function, macro and micro circulation and liver steatosis444Characterization of pig coronary and rabbit aortic lesions using IV-OCT quantitative analysis: correlations with histologyGene therapy and cell therapy447Enhancing the survival and angiogenic potential of mouse atrial mesenchymal cells448VCAM-1 expression in experimental myocardial infarction and its relation to bone marrow-derived mononuclear cell retentionTissue engineering451Advanced multi layered scaffold that increases the maturity of stem cell-derived human cardiomyocytes452Response of engineered heart tissue to simulated ischemia/reperfusion in the presence of acute hyperglycemic conditions453Serum albumin hydrogels prevent de-differentiation of neonatal cardiomyocytes454A novel paintbrush technique for transfer of low viscosity ultraviolet light curable cyan methacrylate on saline immersed in-vitro sheep heart [O] . V Garcia-Martinez, C Lopez Sanchez, W Hamed, 2016

1. Insufficiency of Cellular Energy (ICE) May Precede Neurodegeneration in Alzheimer’s Disease and Be Treatable via the Alternative Cellular Energy (ACE) Pathway [J] . W. John Martin . 阿尔茨海默氏病研究进展（英文） . 2017,第1期

2. Mitochondria-targeted agents: Future perspectives of mitochondrial pharmaceutics in cardiovascular diseases [J] . Thekkuttuparambil Ananthanarayanan Ajith ,Thankamani Gopinathan Jayakumar . 世界心脏病学杂志：英文版（电子版） . 2014,第10期

3. 谱系重编程与肝脏疾病治疗 [C] . 胡以平 . 中国细胞生物学学会细胞工程与转基因生物分会2016年年会 . 2016

4. 十二种疾病特异的iPS系和血小板无力iPS疾病模型的建立以及hESCs胞质中重编程相关因子的检测 [A] . 杜丽丽 . 2012